Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 161952-62-1 | MDL No. : | MFCD13190652 |
Formula : | C7H5BrF3NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QZFCOYMEICRTCT-UHFFFAOYSA-N |
M.W : | 256.02 | Pubchem ID : | 68612295 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 43.43 |
TPSA : | 22.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.76 cm/s |
Log Po/w (iLOGP) : | 2.24 |
Log Po/w (XLOGP3) : | 2.96 |
Log Po/w (WLOGP) : | 4.05 |
Log Po/w (MLOGP) : | 2.11 |
Log Po/w (SILICOS-IT) : | 2.92 |
Consensus Log Po/w : | 2.85 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.44 |
Solubility : | 0.0939 mg/ml ; 0.000367 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.09 |
Solubility : | 0.209 mg/ml ; 0.000818 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.91 |
Solubility : | 0.0313 mg/ml ; 0.000122 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.86 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H312-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18% | Example 31i 5-(3-Bromophenyl)-5-(2-(2,2,2-trifluoroethoxy)pyridin-4-yl)-5H-pyrrolo[3,4-b]pyridin-7-amine tert-Butyllithium (1.6 M in pentane) (1.922 mL, 3.07 mmol) was dropwise added to dry THF (10.00 mL) under argon at -100 C. 4-Bromo-2-(2,2,2-trifluoroethoxy)pyridine (0.328 g, 1.28 mmol) in dry THF (5.000 mL) was added dropwise. The mixture was stirred at -100 C. for 5 min, then N-((3-bromophenyl)(2-cyanopyridin-3-yl)methylene)-2-methylpropane-2-sulfinamide (0.500 g, 1.28 mmol) in dry THF (5.000 mL) was added dropwise. The reaction mixture was stirred at -100 C. for 30 min, then at -70 C. for 2 h. Methanol (5.00 mL) was added and stirring continued for 30 min at -70 C. The cooling bath was removed and stirring continued for additional 30 min. The reaction mixture was concentrated in vacuo. The residue was partitioned between aqueous sodium bicarbonate (sat.) and dichloromethane (*3). The combined organic layers were dried (Na2SO4), filtered and concentrated in vacuo. The residue was filtered through a syringe filter and purified by prep-HPLC to give 5-(3-bromophenyl)-5-(2-(2,2,2-trifluoroethoxy)pyridin-4-yl)-5H-pyrrolo[3,4-b]pyridin-7-amine (0.110 g, 18% yield): 1H NMR (400 MHz, DMSO-d6) delta ppm 8.66-8.69 (m, 1H) 8.40-8.46 (m, 1H) 8.10 (d, 1H) 7.43-7.54 (m, 3H) 7.36-7.42 (m, 1H) 7.28 (t, 1H) 7.08 (dd, 1H) 7.02 (br. s., 2H) 6.81 (dd, 1H) 4.93 (q, 2H); MS (ES+) m/z 463, 465 [M+1]+. ; Example 32i 5-(3-Bromophenyl)-5-(2-(2,2-difluoroyinyloxy)pyridin-4-yl)-5H-pyrrolo[3,4-b]pyridin-7-amine bis(2,2,2-trifluoroacetic acid) tert-Butyllithium (1.6 M in pentane) (1.922 mL, 3.07 mmol) was dropwise added to dry THF (10.00 mL) under argon at -100 C. 4-Bromo-2-(2,2,2-trifluoroethoxy)pyridine (0.328 g, 1.28 mmol) in dry THF (5.000 mL) was added dropwise. The mixture was stirred at -100 C. for 5 min, then N-((3-bromophenyl)(2-cyanopyridin-3-yl)methylene)-2-methylpropane-2-sulfinamide (0.500 g, 1.28 mmol) in dry THF (5.000 mL) was added dropwise. The reaction was stirred at -100 C. for 30 min, then at -70 C. for 1 h. Hydrochloric acid (0.5 M in methanol) (7.69 mL, 3.84 mmol) was added. The mixture was stirred over night while and was allowed to reach room temperature during this time. The reaction mixture was concentrated in vacuo. The residue was partitioned between aqueous sodium bicarbonate (sat.) and dichloromethane (×3). The combined organic layers were dried (Na2SO4), filtered and concentrated in vacuo. Purification by silica chromatography using 0 to 10% (3.5 M ammonia in methanol) in dichloromethane followed by prep-HPLC (Column Gemini NX C18; 21*250 mm; 5 mum; Mobilphase: 20-60% MeCN/H20+0.1% TFA; Flowrate: 20 ml/min) gave 5-(3-bromophenyl)-5-(2-(2,2-difluorovinyloxy)pyridin-4-yl)-5H-pyrrolo[3,4-b]pyridin-7-amine (0.064 g, 7% yield):1H NMR (400 MHz, DMSO-d6) delta ppm 12.28 (br. s., 1H) 10.44 (br. s., 1H) 10.08 (br. s., 1H) 8.99 (dd, 1H) 8.57 (dd, 1H) 8.29 (dd, 1H) 7.91 (dd, 1H) 7.66 (ddd, 1H) 7.47 (t, 1H) 7.40 (t, 1H) 7.24-7.33 (m, 2H) 7.19 (dd, 1H) 7.01-7.06 (m, 1H); MS (ES+) m/z 443, 445 [M+1]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium hydroxide; In dimethyl sulfoxide; at 160℃; for 8.0h; | Dissolve 2,4-dibromopyridine (1.0 g, 4.22 mmol) in 15 mL of dimethyl sulfoxide in a single-necked bottle,Add potassium hydroxide (1.18g, 21.11mmol) and trifluoroethanol(2.11 g, 21.11 mmol). At 160 , the reaction was stirred for 8h.After the reaction, water and ethyl acetate were added, extracted, and the organic phases were combined,The organic phase was washed with saturated brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated,Purification by column chromatography gave the title compound. |
[ 126728-58-3 ]
5-Bromo-2-(2,2,2-trifluoroethoxy)pyridine
Similarity: 0.90
[ 832735-56-5 ]
4-Bromo-2-(difluoromethoxy)pyridine
Similarity: 0.80
[ 884495-00-5 ]
4-Bromo-5-fluoro-2-methoxypyridine
Similarity: 0.74
[ 899452-26-7 ]
5-Bromo-2-(difluoromethoxy)pyridine
Similarity: 0.72
[ 1086393-00-1 ]
3-Bromo-2-(trifluoromethoxy)pyridine
Similarity: 0.70
[ 126728-58-3 ]
5-Bromo-2-(2,2,2-trifluoroethoxy)pyridine
Similarity: 0.90
[ 1289131-55-0 ]
4-Bromo-2-(2-methoxyethoxy)pyridine
Similarity: 0.84
[ 126728-58-3 ]
5-Bromo-2-(2,2,2-trifluoroethoxy)pyridine
Similarity: 0.90
[ 1289131-55-0 ]
4-Bromo-2-(2-methoxyethoxy)pyridine
Similarity: 0.84
[ 126728-58-3 ]
5-Bromo-2-(2,2,2-trifluoroethoxy)pyridine
Similarity: 0.90
[ 1086393-00-1 ]
3-Bromo-2-(trifluoromethoxy)pyridine
Similarity: 0.70
[ 1214377-42-0 ]
5-Bromo-2-methoxy-3-(trifluoromethyl)pyridine
Similarity: 0.69
[ 1227494-05-4 ]
4-Bromo-5-(trifluoromethyl)pyridin-2-ol
Similarity: 0.69
[ 137736-63-1 ]
2-(4-Bromophenoxy)-5-(trifluoromethyl)pyridine
Similarity: 0.68
[ 126728-58-3 ]
5-Bromo-2-(2,2,2-trifluoroethoxy)pyridine
Similarity: 0.90
[ 1289131-55-0 ]
4-Bromo-2-(2-methoxyethoxy)pyridine
Similarity: 0.84